Results 91 to 100 of about 9,040 (224)
Hyperkeratosis of (a) the footpads and (b) the nasal planum. ABSTRACT Background Canine leishmaniosis (CanL) due to Leishmania infantum remains common, and veterinarians do not always follow scientifically sound approaches for diagnosis, treatment and prevention. Objectives To provide consensus guidelines for diagnosis and evidence‐based guidelines for
Manolis N. Saridomichelakis +9 more
wiley +1 more source
A real-time PCR assay to estimate Leishmania chagasi load in its natural sand fly vector Lutzomyia longipalpis [PDF]
Leishmania chagasi, transmitted mainly by Lutzomyia longipalpis sand flies, causes visceral leishmaniasis and atypical cutaneous leishmaniasis in Latin America.
Bates, Paul A. +14 more
core +1 more source
ABSTRACT Chagas disease, caused by the protozoan Trypanosoma cruzi, is a neglected tropical disease with limited treatment options and no available vaccine. Understanding the role of proteins in the parasite's biological cycle is critical for advancing vaccine development and optimizing therapies.
Normanda Souza‐Melo +2 more
wiley +1 more source
ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Hoda Haghshenas +3 more
wiley +1 more source
Glucose Transporters and Virulence in Leishmania mexicana
Glucose transport plays important roles for in vitro growth of insect-stage promastigotes and especially for viability of intramacrophage mammalian host-stage amastigotes of Leishmania mexicana .
Xiuhong Feng +4 more
openaire +3 more sources
Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
In this paper we describe the preparation of some biphenylquinuclidine derivatives and their evaluation as inhibitors of squalene synthase in order to explore their potential in the treatment of the parasitic diseases leishmaniasis and Chagas disease ...
Croft, Simon L +15 more
core +1 more source
PubChem BioAssays 1063: A Poorly Exploited Source of New Antileishmanial Compounds
PubChem Bioassays (AID 1063) reported the in vitro testing of 196,141 compounds against Leishmania major promastigotes. Although these results have been publicly available since 2008, limited efforts on further testing of some of these compounds has been
Sergio Sifontes-Rodríguez +7 more
doaj +1 more source
Production of the Antimicrobial Roseoflavin With Genetically Engineered Corynebacterium glutamicum
Corynebacterium glutamicum was genetically engineered for the production of the riboflavin analog roseoflavin, while minimising its antimicrobial effects. To this end, the genetic machinery from the natural roseoflavin producer Streptomyces davaonensis was evaluated in a riboflavin‐producing C. glutamicum strain.
Luciana Fernandes Brito +4 more
wiley +1 more source
We demonstrate that a proteophosphoglycan-rich gel secreted by Leishmania infantum inside the midgut of Lutzomyia longipalpis sand flies (promastigote secretory gel) is regurgitated along with an average dose of 500 L.
Müller, Ingrid +7 more
core +1 more source
Metabolic variation during development in culture of Leishmania donovani promastigotes
The genome sequencing of several Leishmania species has provided immense amounts of data and allowed the prediction of the metabolic pathways potentially operating.
Cordeiro-da-Silva, Anabela +8 more
core +1 more source

